Advances in Thymic Tumors
A special issue of Cancers (ISSN 2072-6694).
Deadline for manuscript submissions: closed (17 January 2023) | Viewed by 4120
Special Issue Editor
Special Issue Information
Dear Colleagues,
Thymus represents an organ with a remarkable spectrum of neoplastic diseases that derive from its epithelial, lymphatic, and mesenchymal components. Moreover, due to the crucial role of the thymic epithelium in the development of T lymphocytes, many epithelial tumors are accompanied by autoimmune disorders, the prototypical one being the thymoma-associated myasthenia gravis.
The scope of this Special Issue includes but is not limited to pathogenesis, molecular characterization, and therapy of thymic epithelial and lymphatic tumors. Welcome are also manuscripts dealing with autoimmune diseases accompanying thymic tumors.
Prof. Dr. Stefan Porubský
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- thymus
- thymoma
- thymic carcinoma
- lymphoma
- autoimmunity
- myasthenia gravis